Cargando…
COVID-19 and diabetes management: What should be considered?
Autores principales: | Ceriello, Antonio, Stoian, Anca Pantea, Rizzo, Manfredi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7162752/ https://www.ncbi.nlm.nih.gov/pubmed/32305399 http://dx.doi.org/10.1016/j.diabres.2020.108151 |
Ejemplares similares
-
Endocrinology in the Time of COVID-19: A Rapid Evolution of Knowledge and Care
por: Rizvi, Ali A., et al.
Publicado: (2021) -
Telemedicine for diabetes management during COVID-19: what we have learnt, what and how to implement
por: Rosta, Laszlo, et al.
Publicado: (2023) -
Use of Novel Antidiabetic Agents in Patients with Type 2 Diabetes and COVID-19: A Critical Review
por: Popovic, Djordje S., et al.
Publicado: (2021) -
Metabolic Syndrome: From Molecular Mechanisms to Novel Therapies
por: Rizvi, Ali Abbas, et al.
Publicado: (2021) -
Lipoproteins and Cardiovascular Disease: An Update on the Clinical Significance of Atherogenic Small, Dense LDL and New Therapeutical Options
por: Rizvi, Ali A., et al.
Publicado: (2021)